Banner
What Next For Messenger RNA (mRNA)? Maybe Inhalable Vaccines

No one likes getting a needle but most want a vaccine. A new paper shows progress for messenger...

Toward A Single Dose Smallpox And Mpox Vaccine With No Side Effects

Attorney Robert F. Kennedy Jr. and his US followers over the last 25 years have staunchly opposed...

ChatGPT Is Cheaper In Medicine And Does Better Diagnoses Even Than Doctors Using ChatGPT

General medicine, routine visits and such, have gradually gone from M.D.s to including Osteopaths...

Even After Getting Cancer, Quitting Cigarettes Leads To Greater Longevity

Cigarettes are the top lifestyle risk factor for getting cancer, though alcohol and obesity have...

User picture.
News StaffRSS Feed of this column.

News Releases From All Over The World, Right To You... Read More »

Blogroll

In a study appearing in the June 28 issue of JAMA, Peter E. Morris, M.D., of the University of Kentucky, Lexington, and colleagues compared outcomes for standardized rehabilitation therapy to usual intensive care unit (ICU) care for acute respiratory failure.

La Jolla, Calif., June XX, 2016 (embargoed until 11:00 A.M. EST) -- A new study led by scientists at the Sanford Burnham Prebys Medical Discovery Institute (SBP) describes a technology that could lead to new therapeutics for traumatic brain injuries. The discovery, published today in Nature Communications, provides a means of homing drugs or nanoparticles to injured areas of the brain.

"We have found a peptide sequence of four amino acids, cysteine, alanine, glutamine, and lysine (CAQK), that recognizes injured brain tissue," said Erkki Ruoslahti, M.D., Ph.D., distinguished professor in SBP's NCI-Designated Cancer Center and senior author of the study. "This peptide could be used to deliver treatments that limit the extent of damage."

MADISON, Wis. -- University of Wisconsin-Madison researchers studying monkeys have shown that one infection with Zika virus protects against future infection, though pregnancy may drastically prolong the time the virus stays in the body.

The researchers, led by UW-Madison pathology Professor David O'Connor, published a study today (June 28, 2016) in the journal Nature Communications describing their work establishing rhesus macaque monkeys at the Wisconsin National Primate Research Center as a model for studying the way Zika virus infections may progress in people.

Alcohol consumption in Australia has declined steadily during the past decade, with per capita consumption in 2013-14 reaching its lowest level since the early 1960s. A new study published today by the scientific journal Addiction shows that the overall decline in drinking is due mainly to less drinking among people in their teens and early twenties.

BUFFALO, N.Y. - Most people recoil at the thought of ingesting E. coli. But what if the headline-grabbing bacteria could be used to fight disease?

Researchers experimenting with harmless strains of E. coli - yes, the majority of E. coli are safe and important to healthy human digestion - are working toward that goal. Specifically, they have developed an E. coli-based transport capsule designed to help next-generation vaccines do a more efficient and effective job than today's immunizations.

TUCSON, Ariz. - Physicians may be drawing conclusions too soon about survival outcomes of patients who suffered a cardiac arrest outside the hospital.

A study led by Bentley Bobrow, MD, professor at the University of Arizona Colleges of Medicine in Tucson and Phoenix and co-director of the Arizona Emergency Medicine Research Center - Phoenix, and his fellow UA emergency medicine researchers, showed that physicians may need to allow comatose cardiac arrest patients much more time to awaken before making a prognosis.

Gary Brauchla knows this from first-hand experience.